Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor-agonists: Scandinavian cohort studyDiabetes Obes Metab 2021 Nov 05;[EPub Ahead of Print], P Ueda, V Wintzell, E Dahlqwist, B Eliasson, AM Svensson, S Franzén, S Gudbjörnsdottir, K Hveem, C Jonasson, M Melbye, A Hviid, H Svanström, B Pasternak
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.